Persistent URL of this record https://hdl.handle.net/1887/3277576
Documents
-
- Download
- 122572110_publishedVersion_None
- Publisher's Version
- open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: results from the CONKO-005 trial
- All authors
- Hoyer, K.; Hablesreiter, R.; Inoue, Y.; Yoshida, K.; Briest, F.; Christen, F.; Kakiuchi, N.; Yoshizato, T.; Shiozawa, Y.; Shiraishi, Y.; Striefler, J.K.; Bischoff, S.; Lohneis, P.; Putter, H.; Blau, O.; Keilholz, U.; Bullinger, L.; Pelzer, U.; Hummel, M.; Riess, H.; Ogawa, S.; Sinn, M.; Damm, F.
- Date
- 2021-04-01
- Journal
- EBioMedicine
- Volume
- 66